OPDP Enforcement Letters in 2017 Hit Record Low

Drug Industry Daily
A A
The FDA’s Office of Prescription Drug Promotion issued just three warning letters and one untitled letter in calendar year 2017 — a record low and down from a high of 156 in 1998.

To View This Article:

Login

Subscribe To Drug Industry Daily